“pfizer” Archives

in
Entry Author Date Location
Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition 12/14/18 New York
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca 12/03/18 Boston
X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis 11/27/18 Boston
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Data Starts Stretch Run for UniQure’s Upgraded Hemophilia Gene Therapy 11/15/18 Boston
WI Watchlist: EatStreet, Exact Sciences, Northwestern Mutual & More 11/02/18 Wisconsin
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push 10/19/18 San Diego
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam 10/05/18 Boston
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly 09/20/18 Indiana
Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials 09/14/18 San Francisco
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels In $90M 09/05/18 San Francisco
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug 08/30/18 Boston
Eyeing Approval, Pfizer Touts Tafamidis Study, but Details Lacking 08/27/18 New York
Foxconn, Doyenne, Socialeads & More: This Week’s WI Watchlist 08/24/18 Wisconsin
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
Exact Sciences Shares Rise After Company Unveils Pfizer Partnership 08/22/18 Wisconsin
Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results 08/16/18 New York
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug 08/10/18 Boston
Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals 08/03/18 Indiana
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
OUTBio, a Biopharma LGBTQ Group, Grows Fast & Ponders Its Future 07/26/18 Boston
Page 1 of 28 next page »